GPCR Cytoprotective Signaling Mechanisms
GPCR Cytoprotective Signaling Mechanisms
批准号:
9514364
负责人:
Neil C Chi
金额:
$10.01万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-09-01 至 2019-07-31
关键词:
Adherens JunctionApoptosisApoptoticArrestinsBacterial InfectionsBiochemicalBlood VesselsCaveolaeCell membraneCleaved cellClinicalClinical TrialsCytoprotectionCytoskeletonDevelopmentDrug TargetingEdemaEndothelial CellsExperimental ModelsExtravasationFDA approvedFamilyG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGenerationsGoalsHeterotrimeric GTP-Binding ProteinsHumanIn VitroInfectionInflammatory ResponseLigandsLinkMaintenanceMammalian CellMediatingMediator of activation proteinMicroscopyModelingMorbidity - disease ratePAR-1 ReceptorPathway interactionsPharmaceutical PreparationsPreventionReceptor SignalingRegulationReportingRoleSPHK1 enzymeSepsisSignal PathwaySignal TransductionSiteSmall Interfering RNASphingosine-1-Phosphate ReceptorTestingTherapeuticTherapeutic UsesThrombin ReceptorTissuesTransactivationTransgenic AnimalsVascular PermeabilitiesWorkZebrafishactivated Protein Cactivated protein C receptorarrestin 2basebeta-arrestinendothelial dysfunctionexperimental studygenetic manipulationin vivoinsightinterdisciplinary approachmicrobialmortalitymouse modelnovelnovel therapeutic interventionnovel therapeuticspreventpublic health relevancereceptorresponsescaffold
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term goal of this proposal is to identify novel G protein-coupled receptor (GPCR) cytoprotective signaling pathways that can restore or enhance endothelial barrier integrity to prevent vascular leakage associated with sepsis. GPCRs represent the largest family of signaling receptors expressed in mammalian cells and the largest class of drug targets for approved therapeutics. Two GPCRs have been shown to mediate endothelial cytoprotective responses, protease-activated receptor-1 (PAR1) and the sphingosine 1-phosphate receptor-1 (S1PR1). PAR1 is a GPCR for thrombin, but can be cleaved and activated by activated Protein C (APC). APC bound to its co-factor EPCR cleaves the N-terminus of PAR1 at a unique site generating a distinct tethered ligand that promotes cytoprotective signaling. S1PR1 signaling also promotes endothelial barrier maintenance and anti-apoptotic responses and contributes to APC/PAR1-induced cytoprotection. Thus, both PAR1 and S1PR1 make important contributions to endothelial cytoprotection. However, the mechanism by which APC/PAR1 and S1PR1 coordinate cytoprotective signaling in vitro and in vivo is not known and critical to understand to advance the status of these receptors as drug targets for the development of new therapeutics for the prevention and treatment of sepsis. We hypothesize that b-arrestins coordinate APC/PAR1 and S1/S1PR1 signaling in caveolae to promote endothelial cytoprotective responses. We found that APC/PAR1- induced endothelial cytoprotection requires PAR1 localization in caveolae. In recent work, we discovered that APC/PAR1-promoted cytoprotective signaling is mediated by ß-arrestin-2 and dishevelled-2 scaffolds rather than by heterotrimeric G proteins. In preliminary studies we show that PAR1 and S1PR1 co-associate at the plasma membrane and co-exist in caveolae. Moreover, APC/PAR1 induces activation of sphingosine kinase-1 (SK1), an important mediator of S1P generation and S1PR1 activation, through a ß-arrestin-2-dependent pathway. ß-arrestins are also critical for APC-induced anti-apoptotic responses. We further demonstrate using zebrafish that PAR1, S1PR1 and ß-arrestin-2 regulate vascular permeability in a sepsis model. We will pursue a multidisciplinary approach to identify endothelial GPCR cytoprotective protective signaling pathways in vitro using cultured human endothelial cells and in vivo using a zebrafish model of vascular permeability and sepsis. The proposed studies will advance our understanding of how PAR1 and S1PR1 function to regulate vascular endothelial barrier integrity and apoptosis normally and in a sepsis model. The specific aims of the proposal are to: 1) determine how PAR1 and S1PR1 coordinate endothelial cytoprotective signaling, 2) identify the mechanism(s) by which APC/PAR1 integrates with S1P/S1PR1 to promote cytoprotective signaling, and 3) investigate how PAR1, S1PR1 and ß-arrestin-2 regulate endothelial barrier integrity in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)
-
批准号:10753791
-
项目类别:
-
资助金额:$74.1万
-
财政年份:2023
-
负责人:Neil C Chi
-
依托单位:
Cell-Type Specific Mechanisms of HIV Cardiomyopathy
-
批准号:10534777
-
项目类别:
-
资助金额:$70.72万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Cell-Type Specific Mechanisms of HIV Cardiomyopathy
-
批准号:10413721
-
项目类别:
-
资助金额:$71.28万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Genetic regulation of cardiac inflow tract formation in zebrafish
-
批准号:10405548
-
项目类别:
-
资助金额:$49.77万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
-
批准号:10152319
-
项目类别:
-
资助金额:$76.53万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
-
批准号:10852685
-
项目类别:
-
资助金额:$63.63万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
-
批准号:10558570
-
项目类别:
-
资助金额:$76.63万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
-
批准号:10337287
-
项目类别:
-
资助金额:$76.63万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Genetic regulation of cardiac inflow tract formation in zebrafish
-
批准号:10621218
-
项目类别:
-
资助金额:$49.77万
-
财政年份:2021
-
负责人:Neil C Chi
-
依托单位:
Mechanisms of Posterior Heart Field Development
-
批准号:10669667
-
项目类别:
-
资助金额:$51.22万
-
财政年份:2020
-
负责人:Neil C Chi
-
依托单位:
Fine-scale Spatiotemporal Mapping of Cellular Regulatory Networks Directing Heart Development
-
批准号:10223399
-
项目类别:
-
资助金额:$62.59万
-
财政年份:2020
-
负责人:Neil C Chi
-
依托单位:
Fine-scale Spatiotemporal Mapping of Cellular Regulatory Networks Directing Heart Development
-
批准号:10667503
-
项目类别:
-
资助金额:$62.66万
-
财政年份:2020
-
负责人:Neil C Chi
-
依托单位:
Fine-scale Spatiotemporal Mapping of Cellular Regulatory Networks Directing Heart Development
-
批准号:10437807
-
项目类别:
-
资助金额:$62.62万
-
财政年份:2020
-
负责人:Neil C Chi
-
依托单位:
Mechanisms of Posterior Heart Field Development
-
批准号:10462577
-
项目类别:
-
资助金额:$51.19万
-
财政年份:2020
-
负责人:Neil C Chi
-
依托单位:
Mechanisms of Posterior Heart Field Development
-
批准号:10213830
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2020
-
负责人:Neil C Chi
-
依托单位:
Hemodynamic Flow-Mediated Myocardial Reprogramming Impacts Cardiac Development
-
批准号:10155562
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2018
-
负责人:Neil C Chi
-
依托单位:
Hemodynamic Flow-Mediated Myocardial Reprogramming Impacts Cardiac Development
-
批准号:10407993
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2018
-
负责人:Neil C Chi
-
依托单位:
Regulatory Mechanisms of Myocardial Reprogramming in Zebrafish
-
批准号:9311635
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2017
-
负责人:Neil C Chi
-
依托单位:
Regulatory Mechanisms of Myocardial Reprogramming in Zebrafish
-
批准号:9902536
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2017
-
负责人:Neil C Chi
-
依托单位:
Regulatory Mechanisms of Cardiomyocyte Lineage Specification
-
批准号:10067375
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2017
-
负责人:Neil C Chi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: